Cell Therapy Technology Market
By Cell Type (T-Cell, Stem Cell [Bone Marrow, Umbilical Cord Derived, Blood, Others], and Others),
By Therapy (Autologous Therapies and Allogeneic Therapies),
By Therapeutic Area (Malignancies, Musculoskeletal Disorders, Dermatology, and Others)
By Technology (Viral Vector Technology, Genome Editing Technology, Somatic Cell Technology, and Cell Immortalization Technology),
By End Use (Hospitals and Clinics, Educational and Research Institutes and Diagnostic and Regenerative medicine centers), By Region (North America, Europe, Asia-Pacific, Latin America, Middle East & Africa)
Cell Therapy Technology Market - Global Analysis and Forecast 2023-2033
The global Cell therapy technology market showcased a revenue of USD 6.63 billion in 2022 and is projected to witness a compounded annual growth rate (CAGR) of more than 11% over the forecast period of 2023-2033.
Russia-Ukraine War Impact
Market Scope
About the Market
Impact of COVID-19
Global Economic Slowdown
Market Dynamics
Driver
Restrain
Opportunity
Recent Developments
Synopsis
How is this report helpful
FAQ's
Report Coverage
Related Reports
The advent of cell therapy technology is based on transferring healthy, potential, and functional cells into damaged parts or organs to repair or replace damaged tissues. The technology used behind cell therapy is a complex mix of biotechnological techniques and genetic modification approaches. The scientific field is indeed challenging and very exciting. Cell therapy has unlocked cures for diseases through transferring T- cells, enhancing immune functions or even Bone marrow stem cells to cure blood disorders.
The primary growth factor for cell therapy is a rise in chronic disorders coupled with increasing studies and clinical trials on the subject. Cell therapy has been applied in bone marrow transplantation, regenerative treatments, malignancies, and other genetic disorders. It is emerging as an effective tool to cure severe or complex chronic disorders. Advancements in oncology and genetic disorders run parallel with innovations in cell Therapy. Faulted genes or defective cells are sought to get replaced with functional or potent cells, creating path-breaking ways to handle, approach, and cure diseases. The coming years will witness growth in this field owing to ongoing clinical studies and research, looking forward to manifesting the tools and technology in a clinical setting. Neurodegenerative disorders and autoimmune disorders are being sought to get effectively treated by cell therapy.
The field is expected to grow due to continuous efforts to bring cell therapy technology in a clinically accessible form. Clinical settings for cell therapy might be very complex, requiring complex tools to extract, modify and transfer cells. This is being handled by introducing automated cell- and gene-therapy production platforms and GMP (Good manufacturing practices) in clinical settings to boost the market growth. Increasing efforts to bring a commercialized form of cell therapy would cause a boost in the market growth in the coming years.
Impact of the Russia-Ukraine War on the Cell Therapy Technology Market
There is a notable backslash on the cell therapy technology market due to the ongoing Russia Ukraine war, with highest impact being analysed on the European region. The fetal bovine serum (FBS) is an important supplement that is grown in the laboratory that is used for cell therapy technology market. Shift in budget allocation towards war, limited R&D resources and inefficient supply chain has hinder the growth and research of FBS, effect the cell therapy technology market. Furthermore, scientist and researchers on the frontier of cell therapy technology within the European region are fleeing to other nations due to unstable economy and safety, impacting the European cell therapy technology market in long run.
Cell Therapy Technology: Market Scope
The Cell therapy technology market is divided into five segments cell type, therapy, therapeutic area, technology, and end-user. Furthermore, these segments are subdivided into respective categories and cross-referenced to North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa for regional analysis. The cell type segment is further categorized into T-cells or stem cells. The therapy segment is segregated into autologous or allogeneic therapies. Malignancies, Musculoskeletal Disorders, and Dermatology bifurcate the therapeutic area segment of the Cell therapy technology market. The technology segment is distributed into Viral Vector Technology, Genome Editing Technology, Somatic Cell Technology, and Cell Immortalization Technology. With respect to end users, the industry is analyzed by Hospitals and Clinics, Educational and Research Institutes, and Diagnostic and Regenerative medicine centers. Each segment is further classified into regions: North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa. The historical dataset of 2018-2022 is provided in the report, whereas the forecast period of 2023-2033 is offered.
Stem cells will capture the highest market share within the cell type segment
Stem cells are undifferentiated cells that have the potential to grow into any tissue. The concept is much like that of an embryo, where a cluster of cells develops into different types of tissues and organs. The ability of primary stem cells to develop into any specialized tissue is harnessed in stem cell therapy. Thus, Stem cell therapy is expected to capture a higher market share owing to its effective regenerative abilities. Owing to recent developments, stem cell therapy has found its application in orthopedic diseases, autoimmune diseases, metabolic diseases, Neurological diseases, and even cancers. The rise in metabolic disorders (diabetes) and cancer has been gaining significant attention for stem cell therapy approaches, further pushing its market growth.
Allogeneic Therapies would progress with the highest market share
Autologous therapies are often complex due to requirements for first extracting, then modifying, and finally transferring the cells. The requirements and tools can only be installed in a few settings, thus limiting access and availability. Allogeneic therapies are thus a potential solution, gaining more market preference. Allogeneic therapies eliminate complexities, save time, and reduce cost factors. This segment has been increasingly reaching FDA for approval, and also big pharmaceutical firms are making their way into the segment. For instance, the EU did approve the world's first allogeneic T-Cell immunotherapy in the form of Atara Biotherapeutics's Ebvallo. Gilead and Pfizer have also moved into the allogeneic segment.
Malignancies Treatment through cell therapy would witness the highest market share
Cancer biology has been witnessing rising advancements, parallel to the rise in instances of cancer itself. CNN has reported that cancer is striking more people in their 30s and 40s. On the other side, Advances in chimeric antigen receptor (CAR) T-cell therapies have promised significant growth for Cancer treatments. Newer approaches are looking forward to carrying out in-vivo CAR-T gene therapies to effectively cure cancer. Allogeneic CAR T-cell therapy is also sought to be the future of cancer care. In the same line, Poseida Therapeutics is developing a new class of cell and gene therapies with the capacity to cure cancer and rare diseases. Such initiatives are making way for more market opportunities in the treatment of malignant diseases.
Genome Editing Technology to witness the highest growth rate
Rising incidences of genetic disorders and cancers are expected to push the market growth of genome editing technology. This is due to the effective clinical application of Genome editing technology for both genetic disorders and cancers. The rising integration of AI and deep learning techniques primarily carries out this segment's market growth. Large pools of genetic sequences and mutations are being analyzed and predicted using AI. Genetic faults or variations can be effectively predicted using artificial intelligence. Very recently, the University of Zurich has taken the initiative to use artificial intelligence to predict genome editing repair options. This segment is also witnessing increasing market initiatives; for instance, GenKOre signs pacts worth up to $350M in bio bucks for gene editing tech. Similar developments are expected to boost the market growth of genome editing technology in the coming years as well.
Hospitals and Clinics to grab the highest market share
Rise in efforts to make cell therapy accessible and easily installable have been primary factors that aid in the market growth of hospitals and clinics' end-use. Recent developments in platforms that carry out gene or cell therapy in a closed and commercialized setup are being introduced along with good manufacturing practices. These developments and the right guidelines can effectively boost hospital end use of cell therapy. In-vivo therapy options are also being explored in the same line, making way for more market growth.
North America to capture the highest market share
North America has been leading with its increasing Research and development efforts to cure chronic or complex disorders. On the parallel side, America is witnessing increasing chronic disorders. The implications are increased requirements and the development of therapeutic practices.
Impact of COVID-19 on Cell Therapy Technology Industry
COVID-19 created a surge in the biotechnological and pharmaceutical fields. The advent of widespread infection and the evolution of variants triggered various advances in genetic and cellular therapeutic techniques. Vaccine formulation was carried out as dead or weakened viral particle formulation, creating research space for viral DNA and genes. COVID-19 also paved the way for curing diseases through healthy plasma cell transfer. In the whole scenario, COVID-19 positively impacted cell therapy technology's growth.
Cell therapy technology: Market Dynamics
The market dynamics section of the report covers an in-depth analysis of drivers, restraints, and opportunities impacting the Cell therapy technology market. The report also encompasses major market strategies practiced by the industry, followed by patent analysis, product analysis, competitive benchmarking of companies, PORTER and PESTLE analysis of the Cell therapy technology industry, pricing analysis, and geographic competitiveness to provide a detailed understanding. The major players operating the market are Avantor, Inc., Becton, Dickinson, and Company, Danaher Corporation, Fresenius Medical Care AG & Co. KGaA, FUJIFILM Irvine Scientific, Merck KGaA, MaxCyte, Thermo Fisher Scientific Inc. and Terumo BCT. These companies cumulatively hold the majority of the Cell therapy technology market share and actively undergo strategic development, such as new product launches, mergers, collaborations, business expansions, acquisitions, and long-term contracts to ensure market penetration. These companies also largely focus on research and development to gain technological competitiveness in the market. A detailed analysis of these companies is offered in the report.
Driver: Advances in research
Being a relatively challenging field, the driver of this therapy is mainly the scientific research that keeps on bringing new clinical applications of Cell therapy. As per clinical trends, cell therapy has progressed into neurodegenerative disorders such as Parkinson's treatment, cosmetic indications, and Multiple sclerosis. Cell therapy can be significantly effective for Multiple sclerosis, which doesn't have any effective cure yet. Stem cell therapy is also being explored for eye damage treatment, where it offers considerable outcomes. Further research on malignant and non-malignant diseases and their cure by Cell-therapy is also expected to bring more market growth for cell therapy technologies.
Restrain: Lacking skilled labor
Cell therapy is an intermingled field of various disciplines, including genetics, biotechnology, oncology, cellular biology, and more. Effective cell therapy can only be devised using the skills and inputs of skilled representatives from these disciplines. Further, the lack of skilled people to run complex instruments is also restraining the commercial growth of cell therapy. Being a relatively challenging and new field, some cell therapy initiatives might also face constrictions. For instance, The National Medical Commission has recently recommended against the use of stem cell therapy (SCT) in autism spectrum disorder (ASD) after having constituted a committee of experts. Further, the use, promotion, and advertisement for the use of stem cell therapy in children with ASD will be considered professional misconduct.
Opportunities: Rise in chronic disorders
Forecasted years are expected to witness a rise in the geriatric population. Also, recent studies and trends indicate a growing rate of chronic disorders and cancer instances. Cell Therapy is progressing and finding opportunities mainly for chronic conditions where cellular level improvement can cure a disorder for years, as compared to long-term treatments. For instance, Researchers at UT Southwestern Medical Center explored and showed that gene editing can be utilized as an effective cardioprotective strategy for heart disease patients. This indicates a growing opportunity for cell therapy in the cardiovascular treatment segment.
Cell Therapy Technology Market: Recent Developments
- Cellinfinity Bio, a privately held pioneer biotechnology company, has exclusively licensed the technology to develop novel genetically enhanced cell therapy, including engineered CAR-T and CAR-NK products for cancer treatment.
- Researchers at the University of Toronto (U of T) and NYU Grossman School of Medicine have developed a novel artificial intelligence technology called ZFDesign, that can design zinc finger (ZF) proteins to target any stretch of DNA in the human genome, opening a door toward gene therapies for a broader range of health conditions.
- Artiva Biotherapeutics (CA, USA), a clinical-stage oncology company focusing on the delivery of highly effective, off-the-shelf, allogeneic NK cell-based therapies, announced that its lead program, AB-101, has been granted Fast Track Designation by the US FDA for the treatment of relapsed/refractory non-Hodgkin lymphoma of B-cell origin.
Cell Therapy Technology Market: Synopsis
The study of the Cell therapy technology market offers revenue and growth data sets of segments provided at the global, regional, and country levels. The historical data set of 2018-2022 is offered in the report, along with the forecast period of 2023-2033. For the purpose of analysis, Quadrant Market Insights (QMI) has segregated the Cell therapy technology market into five major segments as follows:
By Cell Type
- T-Cell
- Stem Cell
- Bone Marrow
- Umbilical Cord Derived
- Blood
- Others - Others
By Therapy
- Autologous Therapies
- Allogenic Therapies
By Therapeutic Area
- Malignancies
- Musculoskeletal Disorders
- Dermatology
- Others
By Technology
- Viral Vector Technology
- Genome Editing Technology
- Somatic Cell Technology
- Cell Immortalization Technology
- Others
By End Use
- Hospitals and Clinics
- Educational and Research Institutes
- Diagnostic and Regenerative medicine centers
The regional analysis of the cell therapy technology market is as follows:
North America
- U.S.
- Canada
- Mexico
Europe
- UK
- Germany
- France
- Russia
- Italy
- Spain
- Rest of Europe
Asia-Pacific
- China
- India
- Japan
- Australia
- Rest of Asia-Pacific
Latin America
- Brazil
- Mexico
- Argentina
- Chile
Middle East & Africa
- South Africa
- UAE
- Saudi Arabia
- Israel
Key players operating in the cell therapy technology industry are:
- Avantor, Inc.
- Becton, Dickinson, and Company
- Danaher Corporation
- Fresenius Medical Care AG & Co. KGaA
- FUJIFILM Irvine Scientific
- Merck KGaA
- MaxCyte
- Thermo Fisher Scientific Inc.
- Terumo BCT
Cell Therapy Technology Market: Who Should Purchase, and How It Will Help Readers
- The report is best suited for top-level decision-makers, individuals who are supposed to take a leadership role or require market research to start a business, independent researchers, research institutes, and anyone who wishes to gain detailed strategic insights into the cell therapy technology market.
- This report provides a qualitative and quantitative analysis of the market segments, current trends, estimations, and dynamics of the cell therapy technology market analysis from 2018 to 2033 to identify the prevailing market opportunities.
- Market research and information related to key drivers, restraints, and opportunities are offered.
- Porter's five forces and PESTLE analysis highlight the potency of buyers and suppliers to enable stakeholders' market profit-oriented business decisions and strengthen their supplier-buyer network.
- An in-depth analysis of the cell therapy technology segmentation assists in determining the prevailing market opportunities.
- Major countries in each region are mapped according to their revenue contribution to the global market.
- Market player positioning facilitates benchmarking and provides a clear understanding of the present position of the market players.
- The report includes an analysis of the regional and global cell therapy technology industry trends, key players, market segments, application areas, and market growth strategies.
- The report offers insights from primary interviews and CXOs of major industry players. It also offers a comprehensive contact and event repository to ensure future collaborations among industry stakeholders.
Cell Therapy Technology Market: Frequently Asked Questions (FAQ)
Q: How big is the cell therapy technology market?
A: The global Cell therapy technology market showcased a revenue of USD 6.63 billion in 2022 and is projected to witness a compounded annual growth rate (CAGR) of more than 11% over the forecast period of 2023-2033.
Q: Does the report have several cell therapy technology numbers bifurcated by segments and regions?
A: The report offers a total number of cell therapy technology market , further bifurcated into segments and regions. Please refer to the TOC page for more information.
Q: What are the major trends in the cell therapy technology market?
A: Proliferation within the research and application of Cell therapy technology, integration of AI, and rising concern towards chronic diseases and cancer are major factors defining the market of Cell therapy technology within the forecast period.
Q: How can I get the sample Report on the cell therapy technology market?
A: The cell therapy technology market report sample can be obtained on demand from the website. Also, 24*7 chat support and direct call services are provided to procure the sample report
Q: Is it possible to purchase a specific or customized report as per my needs
A: Yes, it is possible to purchase a specific part of the report or edit the scope of the report at your convenience. Feel free to drop us the mail/talk to our customer support or schedule a conversation to procure a customized report.
Report Coverage
- Cell Type
- Therapy
- Therapeutic Area
- Technology
- End Use
- North America
- Europe
- Asia-Pacific
- Latin America
- Middle East & Africa
- Advancement in technological research and development
- Increasing chronic disorder
- Limited skilled labour
Avantor, Inc., Becton, Dickinson, and Company, Danaher Corporation, Fresenius Medical Care AG & Co. KGaA, FUJIFILM Irvine Scientific, Merck KGaA, MaxCyte, Thermo Fisher Scientific Inc. and Terumo BCT.
1. Introduction
1.1 Report Description
1.1.1 Definition
1.1.2 Abbreviations
1.2 Key Market Segments
1.3 Benefits to Stakeholders
1.4 Research Methodology
1.4.1 Market Scoping
1.4.1.1 Problem Identification
1.4.1.2 Defining the Market
1.4.2 Market Estimation
1.4.2.1 Data Mining
1.4.2.2 Product Analysis
1.4.2.3 Application Analysis
1.4.2.4 Market Engineering and Forecasting
1.4.2.4.1 Bottom-up Demand Side
1.4.2.4.2 Bottom-up Supply side
1.4.3 Market Authentication
1.4.3.1 Data Triangulation
1.4.3.1.1 Top-down Supply Side
1.4.3.1.2 Top-down Demand Side
1.4.3.1.3 Data Triangulation
1.4.3.2 Primary Insights and Industry feedback
1.4.4 Report Writing
2. Executive Summary
2.1 Market Snapshot
2.2 Macro Trends, Global Economic Factors and Import/Export Insights
2.3 Primary Insights
2.4 Cell Type Insights
2.5 Therapy Insights
2.6 Therapeutic Area Insights
2.7 Technology Insights
2.8 End Use Insights
2.9 Regional Insights
3. Market Overview
3.1 Market Segment and Scope
3.2 Top Investment Pockets
3.3 Key Strategic Initiatives
3.4 Cell Therapy Technology Market Industry Ecosystem
3.5 Market Evolution
3.6 Patent Analysis
3.7 Technology Landscape
3.8 Regulatory Infrastructure
3.9 Porter’s Analysis
3.9.1 Bargaining Power of Buyer
3.9.2 Bargaining Power of Supplier
3.9.3 Threat of New Entrants
3.9.4 Threat of Substitutes
3.9.5 Industry Rivalry
3.10 PESTLE Analysis
3.11 Market Dynamics
3.11.1 Drivers
3.11.2 Restrains
3.11.3 Opportunities
3.12 Impact of COVID-19 on Cell Therapy Technology Market
3.13 Russia-Ukraine War Impact on Cell Therapy Technology Market
3.14 Growth Share Matrix
3.15 Cell Therapy Technology Market Quadrant
4. Cell Therapy Technology Market, By Cell Type
4.1 Major Impacting Factors, By Cell Type
4.1.1 Key Market Trends and Growth Factors
4.1.2 Market Size and Forecast, by Region, 2018-2033, (USD Billion)
4.1.3 Market Size and Forecast, by Country, 2018-2033, (USD Billion)
4.2 T-Cell
4.2.1 Key Market Trends and Growth Factors
4.2.2 Market Size and Forecast, by Region, 2018-2033, (USD Billion)
4.2.3 Market Size and Forecast, by Country, 2018-2033, (USD Billion)
4.3 Stem Cell
4.3.1 Key Market Trends and Growth Factors
4.3.2 Market Size and Forecast, by Region, 2018-2033, (USD Billion)
4.3.3 Market Size and Forecast, by Country, 2018-2033, (USD Billion)
4.3.4 Bone Marrow
4.3.4.1 Key Market Trends and Growth Factors
4.3.4.2 Market Size and Forecast, by Region, 2018-2033, (USD Billion)
4.3.4.3 Market Size and Forecast, by Country, 2018-2033, (USD Billion)
4.3.5 Umbilical Cord Derived
4.3.5.1 Key Market Trends and Growth Factors
4.3.5.2 Market Size and Forecast, by Region, 2018-2033, (USD Billion)
4.3.5.3 Market Size and Forecast, by Country, 2018-2033, (USD Billion)
4.3.6 Blood
4.3.6.1 Key Market Trends and Growth Factors
4.3.6.2 Market Size and Forecast, by Region, 2018-2033, (USD Billion)
4.3.6.3 Market Size and Forecast, by Country, 2018-2033, (USD Billion)
4.3.7 Others
4.3.7.1 Key Market Trends and Growth Factors
4.3.7.2 Market Size and Forecast, by Region, 2018-2033, (USD Billion)
4.3.7.3 Market Size and Forecast, by Country, 2018-2033, (USD Billion)
4.4 Others
4.4.1 Key Market Trends and Growth Factors
4.4.2 Market Size and Forecast, by Region, 2018-2033, (USD Billion)
4.4.3 Market Size and Forecast, by Country, 2018-2033, (USD Billion)
5. Cell Therapy Technology Market, By Therapy
5.1 Major Impacting Factors, By Therapy
5.1.1 Key Market Trends and Growth Factors
5.1.2 Market Size and Forecast, by Region, 2018-2033, (USD Billion)
5.1.3 Market Size and Forecast, by Country, 2018-2033, (USD Billion)
5.2 Autologous Therapies
5.2.1 Key Market Trends and Growth Factors
5.2.2 Market Size and Forecast, by Region, 2018-2033, (USD Billion)
5.2.3 Market Size and Forecast, by Country, 2018-2033, (USD Billion)
5.3 Allogenic Therapies
5.3.1 Key Market Trends and Growth Factors
5.3.2 Market Size and Forecast, by Region, 2018-2033, (USD Billion)
5.3.3 Market Size and Forecast, by Country, 2018-2033, (USD Billion)
6. Cell Therapy Technology Market, By Therapeutic Area
6.1 Major Impacting Factors, By Therapeutic Area
6.1.1 Key Market Trends and Growth Factors
6.1.2 Market Size and Forecast, by Region, 2018-2033, (USD Billion)
6.1.3 Market Size and Forecast, by Country, 2018-2033, (USD Billion)
6.2 Malignancies
6.2.1 Key Market Trends and Growth Factors
6.2.2 Market Size and Forecast, by Region, 2018-2033, (USD Billion)
6.2.3 Market Size and Forecast, by Country, 2018-2033, (USD Billion)
6.3 Musculoskeletal Disorders
6.3.1 Key Market Trends and Growth Factors
6.3.2 Market Size and Forecast, by Region, 2018-2033, (USD Billion)
6.3.3 Market Size and Forecast, by Country, 2018-2033, (USD Billion)
6.4 Dermatology
6.4.1 Key Market Trends and Growth Factors
6.4.2 Market Size and Forecast, by Region, 2018-2033, (USD Billion)
6.4.3 Market Size and Forecast, by Country, 2018-2033, (USD Billion)
6.5 Others
6.5.1 Key Market Trends and Growth Factors
6.5.2 Market Size and Forecast, by Region, 2018-2033, (USD Billion)
6.5.3 Market Size and Forecast, by Country, 2018-2033, (USD Billion)
7. Cell Therapy Technology Market, By Technology
7.1 Major Impacting Factors, By Technology
7.1.1 Key Market Trends and Growth Factors
7.1.2 Market Size and Forecast, by Region, 2018-2033, (USD Billion)
7.1.3 Market Size and Forecast, by Country, 2018-2033, (USD Billion)
7.2 Viral Vector Technology
7.2.1 Key Market Trends and Growth Factors
7.2.2 Market Size and Forecast, by Region, 2018-2033, (USD Billion)
7.2.3 Market Size and Forecast, by Country, 2018-2033, (USD Billion)
7.3 Genome Editing Technology
7.3.1 Key Market Trends and Growth Factors
7.3.2 Market Size and Forecast, by Region, 2018-2033, (USD Billion)
7.3.3 Market Size and Forecast, by Country, 2018-2033, (USD Billion)
7.4 Somatic Cell Technology
7.4.1 Key Market Trends and Growth Factors
7.4.2 Market Size and Forecast, by Region, 2018-2033, (USD Billion)
7.4.3 Market Size and Forecast, by Country, 2018-2033, (USD Billion)
7.5 Cell Immortalization Technology
7.5.1 Key Market Trends and Growth Factors
7.5.2 Market Size and Forecast, by Region, 2018-2033, (USD Billion)
7.5.3 Market Size and Forecast, by Country, 2018-2033, (USD Billion)
7.6 Others
7.6.1 Key Market Trends and Growth Factors
7.6.2 Market Size and Forecast, by Region, 2018-2033, (USD Billion)
7.6.3 Market Size and Forecast, by Country, 2018-2033, (USD Billion)
8. Cell Therapy Technology Market, By End Use
8.1 Major Impacting Factors, By End Use
8.1.1 Key Market Trends and Growth Factors
8.1.2 Market Size and Forecast, by Region, 2018-2033, (USD Billion)
8.1.3 Market Size and Forecast, by Country, 2018-2033, (USD Billion)
8.2 Hospitals and Clinics
8.2.1 Key Market Trends and Growth Factors
8.2.2 Market Size and Forecast, by Region, 2018-2033, (USD Billion)
8.2.3 Market Size and Forecast, by Country, 2018-2033, (USD Billion)
8.3 Educational and Research Institutes
8.3.1 Key Market Trends and Growth Factors
8.3.2 Market Size and Forecast, by Region, 2018-2033, (USD Billion)
8.3.3 Market Size and Forecast, by Country, 2018-2033, (USD Billion)
8.4 Diagnostic and Regenerative medicine centers
8.4.1 Key Market Trends and Growth Factors
8.4.2 Market Size and Forecast, by Region, 2018-2033, (USD Billion)
8.4.3 Market Size and Forecast, by Country, 2018-2033, (USD Billion)
9. Cell Therapy Technology Market, By Region
9.1 Global Market Trends and Growth Factors
9.2 Market Size and Forecast, by Cell Type, 2018-2033, (USD Billion)
9.2.1 Market Size and Forecast, by Stem Cell, 2018-2033, (USD Billion)
9.3 Market Size and Forecast, by Therapy, 2018-2033, (USD Billion)
9.4 Market Size and Forecast, by Therapeutic Area, 2018-2033, (USD Billion)
9.5 Market Size and Forecast, by Technology, 2018-2033, (USD Billion)
9.6 Market Size and Forecast, by End Use, 2018-2033, (USD Billion)
9.7 Market Size and Forecast, by Region, 2018-2033, (USD Billion)
9.8 North America
9.8.1 Key Market Trends and Growth Factors
9.8.2 Market Size and Forecast, by Cell Type, 2018-2033, (USD Billion)
9.8.2.1 Market Size and Forecast, by Stem Cell, 2018-2033, (USD Billion)
9.8.3 Market Size and Forecast, by Therapy, 2018-2033, (USD Billion)
9.8.4 Market Size and Forecast, by Therapeutic Area, 2018-2033, (USD Billion)
9.8.5 Market Size and Forecast, by Technology, 2018-2033, (USD Billion)
9.8.6 Market Size and Forecast, by End Use, 2018-2033, (USD Billion)
9.8.7 Market Size and Forecast, by Country, 2018-2033, (USD Billion)
9.8.8 U.S.
9.8.8.1 Market Size and Forecast, by Cell Type, 2018-2033, (USD Billion)
9.8.8.1.1 Market Size and Forecast, by Stem Cell, 2018-2033, (USD Billion)
9.8.8.2 Market Size and Forecast, by Therapy, 2018-2033, (USD Billion)
9.8.8.3 Market Size and Forecast, by Therapeutic Area, 2018-2033, (USD Billion)
9.8.8.4 Market Size and Forecast, by Technology, 2018-2033, (USD Billion)
9.8.8.5 Market Size and Forecast, by End Use, 2018-2033, (USD Billion)
9.8.9 Canada
9.8.9.1 Market Size and Forecast, by Cell Type, 2018-2033, (USD Billion)
9.8.9.1.1 Market Size and Forecast, by Stem Cell, 2018-2033, (USD Billion)
9.8.9.2 Market Size and Forecast, by Therapy, 2018-2033, (USD Billion)
9.8.9.3 Market Size and Forecast, by Therapeutic Area, 2018-2033, (USD Billion)
9.8.9.4 Market Size and Forecast, by Technology, 2018-2033, (USD Billion)
9.8.9.5 Market Size and Forecast, by End Use, 2018-2033, (USD Billion)
9.8.10 Mexico
9.8.10.1 Market Size and Forecast, by Cell Type, 2018-2033, (USD Billion)
9.8.10.1.1 Market Size and Forecast, by Stem Cell, 2018-2033, (USD Billion)
9.8.10.2 Market Size and Forecast, by Therapy, 2018-2033, (USD Billion)
9.8.10.3 Market Size and Forecast, by Therapeutic Area, 2018-2033, (USD Billion)
9.8.10.4 Market Size and Forecast, by Technology, 2018-2033, (USD Billion)
9.8.10.5 Market Size and Forecast, by End Use, 2018-2033, (USD Billion)
9.9 Europe
9.9.1 Key Market Trends and Growth Factors
9.9.2 Market Size and Forecast, by Cell Type, 2018-2033, (USD Billion)
9.9.2.1 Market Size and Forecast, by Stem Cell, 2018-2033, (USD Billion)
9.9.3 Market Size and Forecast, by Therapy, 2018-2033, (USD Billion)
9.9.4 Market Size and Forecast, by Therapeutic Area, 2018-2033, (USD Billion)
9.9.5 Market Size and Forecast, by Technology, 2018-2033, (USD Billion)
9.9.6 Market Size and Forecast, by End Use, 2018-2033, (USD Billion)
9.9.7 Market Size and Forecast, by Country, 2018-2033, (USD Billion)
9.9.8 UK
9.9.8.1 Market Size and Forecast, by Cell Type, 2018-2033, (USD Billion)
9.9.8.1.1 Market Size and Forecast, by Stem Cell, 2018-2033, (USD Billion)
9.9.8.2 Market Size and Forecast, by Therapy, 2018-2033, (USD Billion)
9.9.8.3 Market Size and Forecast, by Therapeutic Area, 2018-2033, (USD Billion)
9.9.8.4 Market Size and Forecast, by Technology, 2018-2033, (USD Billion)
9.9.8.5 Market Size and Forecast, by End Use, 2018-2033, (USD Billion)
9.9.9 Germany
9.9.9.1 Market Size and Forecast, by Cell Type, 2018-2033, (USD Billion)
9.9.9.1.1 Market Size and Forecast, by Stem Cell, 2018-2033, (USD Billion)
9.9.9.2 Market Size and Forecast, by Therapy, 2018-2033, (USD Billion)
9.9.9.3 Market Size and Forecast, by Therapeutic Area, 2018-2033, (USD Billion)
9.9.9.4 Market Size and Forecast, by Technology, 2018-2033, (USD Billion)
9.9.9.5 Market Size and Forecast, by End Use, 2018-2033, (USD Billion)
9.9.10 France
9.9.10.1 Market Size and Forecast, by Cell Type, 2018-2033, (USD Billion)
9.9.10.1.1 Market Size and Forecast, by Stem Cell, 2018-2033, (USD Billion)
9.9.10.2 Market Size and Forecast, by Therapy, 2018-2033, (USD Billion)
9.9.10.3 Market Size and Forecast, by Therapeutic Area, 2018-2033, (USD Billion)
9.9.10.4 Market Size and Forecast, by Technology, 2018-2033, (USD Billion)
9.9.10.5 Market Size and Forecast, by End Use, 2018-2033, (USD Billion)
9.9.11 Russia
9.9.11.1 Market Size and Forecast, by Cell Type, 2018-2033, (USD Billion)
9.9.11.1.1 Market Size and Forecast, by Stem Cell, 2018-2033, (USD Billion)
9.9.11.2 Market Size and Forecast, by Therapy, 2018-2033, (USD Billion)
9.9.11.3 Market Size and Forecast, by Therapeutic Area, 2018-2033, (USD Billion)
9.9.11.4 Market Size and Forecast, by Technology, 2018-2033, (USD Billion)
9.9.11.5 Market Size and Forecast, by End Use, 2018-2033, (USD Billion)
9.9.12 Italy
9.9.12.1 Market Size and Forecast, by Cell Type, 2018-2033, (USD Billion)
9.9.12.1.1 Market Size and Forecast, by Stem Cell, 2018-2033, (USD Billion)
9.9.12.2 Market Size and Forecast, by Therapy, 2018-2033, (USD Billion)
9.9.12.3 Market Size and Forecast, by Therapeutic Area, 2018-2033, (USD Billion)
9.9.12.4 Market Size and Forecast, by Technology, 2018-2033, (USD Billion)
9.9.12.5 Market Size and Forecast, by End Use, 2018-2033, (USD Billion)
9.9.13 Rest of Europe
9.9.13.1 Market Size and Forecast, by Cell Type, 2018-2033, (USD Billion)
9.9.13.1.1 Market Size and Forecast, by Stem Cell, 2018-2033, (USD Billion)
9.9.13.2 Market Size and Forecast, by Therapy, 2018-2033, (USD Billion)
9.9.13.3 Market Size and Forecast, by Therapeutic Area, 2018-2033, (USD Billion)
9.9.13.4 Market Size and Forecast, by Technology, 2018-2033, (USD Billion)
9.9.13.5 Market Size and Forecast, by End Use, 2018-2033, (USD Billion)
9.10 Asia-Pacific
9.10.1 Key Market Trends and Growth Factors
9.10.2 Market Size and Forecast, by Cell Type, 2018-2033, (USD Billion)
9.10.2.1 Market Size and Forecast, by Stem Cell, 2018-2033, (USD Billion)
9.10.3 Market Size and Forecast, by Therapy, 2018-2033, (USD Billion)
9.10.4 Market Size and Forecast, by Therapeutic Area, 2018-2033, (USD Billion)
9.10.5 Market Size and Forecast, by Technology, 2018-2033, (USD Billion)
9.10.6 Market Size and Forecast, by End Use, 2018-2033, (USD Billion)
9.10.7 Market Size and Forecast, by Country, 2018-2033, (USD Billion)
9.10.8 China
9.10.8.1 Market Size and Forecast, by Cell Type, 2018-2033, (USD Billion)
9.10.8.1.1 Market Size and Forecast, by Stem Cell, 2018-2033, (USD Billion)
9.10.8.2 Market Size and Forecast, by Therapy, 2018-2033, (USD Billion)
9.10.8.3 Market Size and Forecast, by Therapeutic Area, 2018-2033, (USD Billion)
9.10.8.4 Market Size and Forecast, by Technology, 2018-2033, (USD Billion)
9.10.8.5 Market Size and Forecast, by End Use, 2018-2033, (USD Billion)
9.10.9 India
9.10.9.1 Market Size and Forecast, by Cell Type, 2018-2033, (USD Billion)
9.10.9.1.1 Market Size and Forecast, by Stem Cell, 2018-2033, (USD Billion)
9.10.9.2 Market Size and Forecast, by Therapy, 2018-2033, (USD Billion)
9.10.9.3 Market Size and Forecast, by Therapeutic Area, 2018-2033, (USD Billion)
9.10.9.4 Market Size and Forecast, by Technology, 2018-2033, (USD Billion)
9.10.9.5 Market Size and Forecast, by End Use, 2018-2033, (USD Billion)
9.10.10 Japan
9.10.10.1 Market Size and Forecast, by Cell Type, 2018-2033, (USD Billion)
9.10.10.1.1 Market Size and Forecast, by Stem Cell, 2018-2033, (USD Billion)
9.10.10.2 Market Size and Forecast, by Therapy, 2018-2033, (USD Billion)
9.10.10.3 Market Size and Forecast, by Therapeutic Area, 2018-2033, (USD Billion)
9.10.10.4 Market Size and Forecast, by Technology, 2018-2033, (USD Billion)
9.10.10.5 Market Size and Forecast, by End Use, 2018-2033, (USD Billion)
9.10.11 Australia
9.10.11.1 Market Size and Forecast, by Cell Type, 2018-2033, (USD Billion)
9.10.11.1.1 Market Size and Forecast, by Stem Cell, 2018-2033, (USD Billion)
9.10.11.2 Market Size and Forecast, by Therapy, 2018-2033, (USD Billion)
9.10.11.3 Market Size and Forecast, by Therapeutic Area, 2018-2033, (USD Billion)
9.10.11.4 Market Size and Forecast, by Technology, 2018-2033, (USD Billion)
9.10.11.5 Market Size and Forecast, by End Use, 2018-2033, (USD Billion)
9.10.12 Rest of Asia-Pacific
9.10.12.1 Market Size and Forecast, by Cell Type, 2018-2033, (USD Billion)
9.10.12.1.1 Market Size and Forecast, by Stem Cell, 2018-2033, (USD Billion)
9.10.12.2 Market Size and Forecast, by Therapy, 2018-2033, (USD Billion)
9.10.12.3 Market Size and Forecast, by Therapeutic Area, 2018-2033, (USD Billion)
9.10.12.4 Market Size and Forecast, by Technology, 2018-2033, (USD Billion)
9.10.12.5 Market Size and Forecast, by End Use, 2018-2033, (USD Billion)
9.11 Latin America
9.11.1 Key Market Trends and Growth Factors
9.11.2 Market Size and Forecast, by Cell Type, 2018-2033, (USD Billion)
9.11.2.1 Market Size and Forecast, by Stem Cell, 2018-2033, (USD Billion)
9.11.3 Market Size and Forecast, by Therapy, 2018-2033, (USD Billion)
9.11.4 Market Size and Forecast, by Therapeutic Area, 2018-2033, (USD Billion)
9.11.5 Market Size and Forecast, by Technology, 2018-2033, (USD Billion)
9.11.6 Market Size and Forecast, by End Use, 2018-2033, (USD Billion)
9.11.7 Market Size and Forecast, by Country, 2018-2033, (USD Billion)
9.11.8 Brazil
9.11.8.1 Market Size and Forecast, by Cell Type, 2018-2033, (USD Billion)
9.11.8.1.1 Market Size and Forecast, by Stem Cell, 2018-2033, (USD Billion)
9.11.8.2 Market Size and Forecast, by Therapy, 2018-2033, (USD Billion)
9.11.8.3 Market Size and Forecast, by Therapeutic Area, 2018-2033, (USD Billion)
9.11.8.4 Market Size and Forecast, by Technology, 2018-2033, (USD Billion)
9.11.8.5 Market Size and Forecast, by End Use, 2018-2033, (USD Billion)
9.11.9 Argentina
9.11.9.1 Market Size and Forecast, by Cell Type, 2018-2033, (USD Billion)
9.11.9.1.1 Market Size and Forecast, by Stem Cell, 2018-2033, (USD Billion)
9.11.9.2 Market Size and Forecast, by Therapy, 2018-2033, (USD Billion)
9.11.9.3 Market Size and Forecast, by Therapeutic Area, 2018-2033, (USD Billion)
9.11.9.4 Market Size and Forecast, by Technology, 2018-2033, (USD Billion)
9.11.9.5 Market Size and Forecast, by End Use, 2018-2033, (USD Billion)
9.11.10 Mexico
9.11.10.1 Market Size and Forecast, by Cell Type, 2018-2033, (USD Billion)
9.11.10.1.1 Market Size and Forecast, by Stem Cell, 2018-2033, (USD Billion)
9.11.10.2 Market Size and Forecast, by Therapy, 2018-2033, (USD Billion)
9.11.10.3 Market Size and Forecast, by Therapeutic Area, 2018-2033, (USD Billion)
9.11.10.4 Market Size and Forecast, by Technology, 2018-2033, (USD Billion)
9.11.10.5 Market Size and Forecast, by End Use, 2018-2033, (USD Billion)
9.11.11 Chile
9.11.11.1 Market Size and Forecast, by Cell Type, 2018-2033, (USD Billion)
9.11.11.1.1 Market Size and Forecast, by Stem Cell, 2018-2033, (USD Billion)
9.11.11.2 Market Size and Forecast, by Therapy, 2018-2033, (USD Billion)
9.11.11.3 Market Size and Forecast, by Therapeutic Area, 2018-2033, (USD Billion)
9.11.11.4 Market Size and Forecast, by Technology, 2018-2033, (USD Billion)
9.11.11.5 Market Size and Forecast, by End Use, 2018-2033, (USD Billion)
9.12 Middle East and Africa
9.12.1 Key Market Trends and Growth Factors
9.12.2 Market Size and Forecast, by Cell Type, 2018-2033, (USD Billion)
9.12.2.1 Market Size and Forecast, by Stem Cell, 2018-2033, (USD Billion)
9.12.3 Market Size and Forecast, by Therapy, 2018-2033, (USD Billion)
9.12.4 Market Size and Forecast, by Therapeutic Area, 2018-2033, (USD Billion)
9.12.5 Market Size and Forecast, by Technology, 2018-2033, (USD Billion)
9.12.6 Market Size and Forecast, by End Use, 2018-2033, (USD Billion)
9.12.7 Market Size and Forecast, by Country, 2018-2033, (USD Billion)
9.12.8 South Africa
9.12.8.1 Market Size and Forecast, by Cell Type, 2018-2033, (USD Billion)
9.12.8.1.1 Market Size and Forecast, by Stem Cell, 2018-2033, (USD Billion)
9.12.8.2 Market Size and Forecast, by Therapy, 2018-2033, (USD Billion)
9.12.8.3 Market Size and Forecast, by Therapeutic Area, 2018-2033, (USD Billion)
9.12.8.4 Market Size and Forecast, by Technology, 2018-2033, (USD Billion)
9.12.8.5 Market Size and Forecast, by End Use, 2018-2033, (USD Billion)
9.12.9 UAE
9.12.9.1 Market Size and Forecast, by Cell Type, 2018-2033, (USD Billion)
9.12.9.1.1 Market Size and Forecast, by Stem Cell, 2018-2033, (USD Billion)
9.12.9.2 Market Size and Forecast, by Therapy, 2018-2033, (USD Billion)
9.12.9.3 Market Size and Forecast, by Therapeutic Area, 2018-2033, (USD Billion)
9.12.9.4 Market Size and Forecast, by Technology, 2018-2033, (USD Billion)
9.12.9.5 Market Size and Forecast, by End Use, 2018-2033, (USD Billion)
9.12.10 Saudi Arabia
9.12.10.1 Market Size and Forecast, by Cell Type, 2018-2033, (USD Billion)
9.12.10.1.1 Market Size and Forecast, by Stem Cell, 2018-2033, (USD Billion)
9.12.10.2 Market Size and Forecast, by Therapy, 2018-2033, (USD Billion)
9.12.10.3 Market Size and Forecast, by Therapeutic Area, 2018-2033, (USD Billion)
9.12.10.4 Market Size and Forecast, by Technology, 2018-2033, (USD Billion)
9.12.10.5 Market Size and Forecast, by End Use, 2018-2033, (USD Billion)
9.12.11 Israel
9.12.11.1 Market Size and Forecast, by Cell Type, 2018-2033, (USD Billion)
9.12.11.1.1 Market Size and Forecast, by Stem Cell, 2018-2033, (USD Billion)
9.12.11.2 Market Size and Forecast, by Therapy, 2018-2033, (USD Billion)
9.12.11.3 Market Size and Forecast, by Therapeutic Area, 2018-2033, (USD Billion)
9.12.11.4 Market Size and Forecast, by Technology, 2018-2033, (USD Billion)
9.12.11.5 Market Size and Forecast, by End Use, 2018-2033, (USD Billion)
10. Competitive Benchmarking & Company Profiles
10.1 Competitive Benchmarking
10.1.1 Company Market Share
10.1.2 Product Mapping
10.1.3 Competitive Heat map
10.2 Avantor, Inc.
10.2.1 Company Overview
10.2.2 Financial Analysis
10.2.3 Product Offering
10.2.4 Strategic Initiatives
10.2.5 SWOT
10.2.6 Ansoff Matrix
10.3 Becton, Dickinson, and Company
10.3.1 Company Overview
10.3.2 Financial Analysis
10.3.3 Product Offering
10.3.4 Strategic Initiatives
10.3.5 SWOT
10.3.6 Ansoff Matrix
10.4 Danaher Corporation
10.4.1 Company Overview
10.4.2 Financial Analysis
10.4.3 Product Offering
10.4.4 Strategic Initiatives
10.4.5 SWOT
10.4.6 Ansoff Matrix
10.5 Fresenius Medical Care AG & Co. KGaA
10.5.1 Company Overview
10.5.2 Financial Analysis
10.5.3 Product Offering
10.5.4 Strategic Initiatives
10.5.5 SWOT
10.5.6 Ansoff Matrix
10.6 FUJIFILM Irvine Scientific
10.6.1 Company Overview
10.6.2 Financial Analysis
10.6.3 Product Offering
10.6.4 Strategic Initiatives
10.6.5 SWOT
10.6.6 Ansoff Matrix
10.7 Merck KGaA
10.7.1 Company Overview
10.7.2 Financial Analysis
10.7.3 Product Offering
10.7.4 Strategic Initiatives
10.7.5 SWOT
10.7.6 Ansoff Matrix
10.8 MaxCyte
10.8.1 Company Overview
10.8.2 Financial Analysis
10.8.3 Product Offering
10.8.4 Strategic Initiatives
10.8.5 SWOT
10.8.6 Ansoff Matrix
10.9 Thermo Fisher Scientific Inc.
10.9.1 Company Overview
10.9.2 Financial Analysis
10.9.3 Product Offering
10.9.4 Strategic Initiatives
10.9.5 SWOT
10.9.6 Ansoff Matrix
10.10 Terumo BCT
10.10.1 Company Overview
10.10.2 Financial Analysis
10.10.3 Product Offering
10.10.4 Strategic Initiatives
10.10.5 SWOT
10.10.6 Ansoff Matrix
11. Industry Connects and Upcoming Seminars
.webp)
